Mueller Peter

Mueller Peter is listed in filings as Director at BioXcel Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 12, 2026, including 2 public disclosures. Recent filings connect the profile to BioXcel Therapeutics, Inc. (BTAI). The current snapshot covers public activity from Jun 11, 2024 to Jan 12, 2026. Reported amounts are shown as $34.2K to $24.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.